Pharmaceutical penny stocks 2016

A solid employment report for December helped to fan the bullish flames. TRegeneron Pharmaceuticals Inc NASDAQ: REGN and Teva Pharmaceutical Industries Ltd ADR NYSE: TEVA each ended the day in the red, and by more than a little bit.

Drugmaker Teva Pharmaceutical ended the week on a dire note, announcing a lackluster sales and earnings outlook. Regeneron Pharmaceuticals was also the victim of a surprising and a relatively unusual decision by a federal judge ordering the company to take its cholesterol fighting drug Praluent.

The judge determined that Praluent infringed on a nearly identical drug called Repatha, jointly made by Sanofi SA ADR NYSE: SNY and Amgen, Inc.

Top 10 Stocks - Best 10 Stocks

Amgen shares, on the other hand, advanced 2. TWX would likely sidestep any Federal Communications Commission concerns by simply divesting one television station, President-elect Donald Trump chimed in again with his distaste of the idea.

But, the Pharmaceutical penny stocks 2016 does wield a great deal borrow stock broker influence, and may be able to cultivate a headwind that bars the deal.

As of this writing, James Brumley did not hold a position in any of the aforementioned securities.

Invest in Biotech Penny Stocks in

Article printed from InvestorPlace Media, http: Financial Market Data powered by FinancialContent Services, Inc. Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes. Stocks to Buy Stocks to Sell Dividend Stocks Penny Stocks Hot Stocks Stock Market Today.

Breaking news sponsored by googletag. More on InvestorPlace 7 Monthly Dividend Stocks to Pay Your Bills Regularly Twitter Is Soaring.

This Is Your Play. Advanced Micro Devices, Inc. View and vote in our How confident are you about the U. Choose A Page About Us Press Center Resources Advisory Services Free Newsletters Free Reports Contact Us Advertise With Us Employment Privacy Terms and Conditions Disclosures and Disclaimers Media Sites Sitemap jQuery " footer-links".